deKay, Joanne T.
Emery, Ivette F.
Rud, Jonathan
Eldridge, Ashley
Lord, Christine
Gagnon, David J.
May, Teresa L.
Herrera, Victoria L. M.
Ruiz-Opazo, Nelson
Riker, Richard R.
Sawyer, Douglas B.
Ryzhov, Sergey
Seder, David B.
Funding for this research was provided by:
NIH/NIGMS (U54GM115516, P20GM139745)
NIH (U54HL119145, P30GM106391)
Article History
Received: 19 May 2021
Accepted: 8 November 2021
First Online: 17 November 2021
Competing interests
: Victoria L. M. Herrera and Nelson Ruiz-Opazo are co-inventors on Boston University patents on DEspR; co-scientific founders of NControl Therapeutics, Inc., with the option to license DEspR intellectual property from Boston University. All other co-authors have no competing interests.